Further research is also needed to investigate if NOD2 expression in phagocytes may favor colorectal cancer through limiting lysozyme-dependent anti-cancer properties such as direct activation of immune effectors and immunosuppressive antioxidant properties (52). This evidence concerns the gene NOD2 and cancer.